Literature DB >> 10326067

Lifetime risk of hip fractures is underestimated.

A Oden1, A Dawson, W Dere, O Johnell, B Jonsson, J A Kanis.   

Abstract

Estimates of lifetime risk of osteoporotic fracture have assumed that mortality rates do not change. Since mortality in the elderly is decreasing in all regions of the world we assessed the effect of this on lifetime risks for hip fracture using Sweden as a reference country. Lifetime risks of hip fracture at the age of 50 years were 4.6% and 13.9% in men and women respectively, assuming all survive to current average life expectancy. Estimates increased to 8.1% and 19.5% when based on present mortality and to 11.1% and 22.7% respectively based on predicted mortality. We conclude that lifetime risks of hip fracture have been considerably underestimated.

Entities:  

Mesh:

Year:  1998        PMID: 10326067     DOI: 10.1007/s001980050105

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  51 in total

Review 1.  The burden of osteoporosis.

Authors:  J A Kanis; O Johnell
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

2.  Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective.

Authors:  F Borgström; O Ström; M Kleman; E McCloskey; H Johansson; A Odén; J A Kanis
Journal:  Osteoporos Int       Date:  2010-06-08       Impact factor: 4.507

3.  Proximal hip geometry is linked to several chromosomal regions: genome-wide linkage results from the Framingham Osteoporosis Study.

Authors:  S Demissie; J Dupuis; L A Cupples; T J Beck; D P Kiel; D Karasik
Journal:  Bone       Date:  2006-10-31       Impact factor: 4.398

4.  Bivariate linkage study of proximal hip geometry and body size indices: the Framingham study.

Authors:  D Karasik; J Dupuis; L A Cupples; T J Beck; M C Mahaney; L M Havill; D P Kiel; S Demissie
Journal:  Calcif Tissue Int       Date:  2007-08-03       Impact factor: 4.333

Review 5.  Assessment of fracture risk.

Authors:  John A Kanis; Frederik Borgstrom; Chris De Laet; Helena Johansson; Olof Johnell; Bengt Jonsson; Anders Oden; Niklas Zethraeus; Bruce Pfleger; Nikolai Khaltaev
Journal:  Osteoporos Int       Date:  2004-12-23       Impact factor: 4.507

6.  The Ability of a Single BMD and Fracture History Assessment to Predict Fracture Over 25 Years in Postmenopausal Women: The Study of Osteoporotic Fractures.

Authors:  Dennis M Black; Jane A Cauley; Rachel Wagman; Kristine Ensrud; Howard A Fink; Teresa A Hillier; Li-Yung Lui; Steven R Cummings; John T Schousboe; Nicola Napoli
Journal:  J Bone Miner Res       Date:  2017-07-18       Impact factor: 6.741

7.  Polymorphisms in the endothelial nitric oxide synthase gene and bone density/ultrasound and geometry in humans.

Authors:  K Cho; S Demissie; J Dupuis; L A Cupples; S Kathiresan; T J Beck; D Karasik; D P Kiel
Journal:  Bone       Date:  2007-09-29       Impact factor: 4.398

Review 8.  Hormone therapy for the prevention of bone loss in menopausal women with osteopenia: is it a viable option?

Authors:  Mary H Hohenhaus; Kelly A McGarry; Nananda F Col
Journal:  Drugs       Date:  2007       Impact factor: 9.546

9.  Osteoporosis in a female population from Bratislava--age-related BMD changes.

Authors:  Jaroslava Wendlová; Viera Pacáková
Journal:  Wien Med Wochenschr       Date:  2007

10.  The cost-effectiveness of strontium ranelate in the UK for the management of osteoporosis.

Authors:  F Borgström; O Ström; J Coelho; H Johansson; A Oden; E McCloskey; J A Kanis
Journal:  Osteoporos Int       Date:  2009-06-10       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.